Overview

Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
To establish bioequivalence of ritonavir generic capsule, with Norvir® as reference drug.
Phase:
Phase 1
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborator:
The Government Pharmaceutical Organization
Treatments:
Ritonavir